skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Optimal timing for antihypertensive dosing: focus on valsartan

(2521) Views  (527) Full article downloads

Authors: Ramón C Hermida, Diana E Ayala, Carlos Calvo

Published Date February 2007 Volume 2007:3(1) Pages 119 - 131
DOI: http://dx.doi.org/10.2147/TCRM.S

Ramón C Hermida1, Diana E Ayala1, Carlos Calvo2

1Bioengineering & Chronobiology Laboratories, University of Vigo, Campus Universitario, Vigo, 36200 Spain; 2Hypertension and Vascular Risk Unit, Hospital Clinico Universitario, Santiago de Compostela, 15706 Spain

Abstract: Some specific features of the 24 h blood pressure (BP) pattern are linked to the progressive injury of target tissues and the triggering of cardiac and cerebrovascular events. In particular, many studies show the extent of the nocturnal BP decline relative to the diurnal BP mean (the diurnal/nocturnal ratio, an index of BP dipping) is deterministic of cardiovascular injury and risk. Normalization of the circadian BP pattern is considered to be an important clinical goal of pharmacotherapy because it may slow the advance of renal injury and avert end-stage renal failure. The chronotherapy of hypertension takes into account the epidemiology of the BP pattern, plus potential administration-time determinants of the pharmacokinetics and dynamics of antihypertensive medications, as a means of enhancing beneficial outcomes and/or attenuating or averting adverse effects. Thus, bedtime dosing with nifedipine gastrointestinal therapeutic system (GITS) is more effective than morning dosing, while also reducing significantly secondary effects. The dose-response curve, therapeutic coverage, and efficacy of doxazosin GITS are all markedly dependent on the circadian time of drug administration. Moreover, valsartan administration at bedtime as opposed to upon wakening results in improved diurnal/nocturnal ratio, a significant increase in the percentage of patients with controlled BP after treatment, and significant reductions in urinary albumin excretion and plasma fibrinogen. Chronotherapy provides a means of individualizing treatment of hypertension according to the circadian BP profile of each patient, and constitutes a new option to optimize BP control and reduce risk.

Keywords: valsartan, ambulatory blood pressure monitoring, dipper, nondipper, hypertension, chronotherapy, circadian rhythm








Readers of this article also read:

Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom
Tramadol extended-release in the management of chronic pain
Critical appraisal of a fixed combination of esomeprazole and low dose aspirin in risk reduction
Assessment and management of nutrition in older people and its importance to health
The role of herpesviruses in ocular infections
Reporting of results of interventional studies by the information service of the National Institutes of Health
Analgesic efficacy of oral gabapentin added to standard epidural corticosteroids in patients with failed back surgery
Using systematically observed clinical encounters (SOCEs) to assess medical students’ skills in clinical settings
Olmesartan/amlodipine: a review of its use in the management of hypertension
Reappraisal of role of angiotensin receptor blockers in cardiovascular protection